Gaurav Varma

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 7

Top Topics

Low Density Lipoprotein

Multiple Myeloma

Structural Basis

Top Venues

Clinical cancer research : an official journal of the American Association for Cancer Research

Expert review of anticancer therapy

This page only lists publications with an associated author ORCID identifier.

Publications

Gaurav Varma, Catherine S Diefenbach
KLRG1, Another Opportunity for a Breakthrough in MTCL. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (11) (2024)
Gaurav Varma, Catherine S Diefenbach
KLRG1, Another Opportunity for a Breakthrough in MTCL. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (11) (2024)
Gaurav Varma, Catherine S Diefenbach
KLRG1, Another Opportunity for a Breakthrough in MTCL. Clinical cancer research : an official journal of the American Association for Cancer Research (2024)
Gaurav Varma, Catherine S Diefenbach
On the Precipice of a "Rituximab-Like" Era for T-cell Lymphomas? Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Eileen Mary Boyle, Patrick Blaney, James H Stoeckle, Yubao Wang, Hussein Ghamlouch, Dylan Gagler, Marc J Braunstein, Louis Williams, Avital Tenenbaum, Ariel M Siegel, Xiaoyi Chen, Gaurav Varma, Jason Avigan, Alexander Li, Monica Jinsi, David Kaminetzky, Arnaldo Arbini, Lydiane Mordier, Jill Corre, Even Holth Rustad, Carl Ola Landgren, Francesco Maura, Brian A Walker, Michael A Bauer, Benedetto Bruno, Aristotelis Tsirigos, Faith E Davies, Gareth J Morgan
Multiomic mapping of acquired chromosome 1 copy number and structural variants to identify therapeutic vulnerabilities in multiple myeloma. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Gaurav Varma, Jacqueline Wang, Catherine Diefenbach
Polatuzumab vedotin in relapsed / refractory aggressive B-cell lymphoma. Expert review of anticancer therapy 22 (8) (2022)
Juan Pablo Alderuccio, Adam J Olszewski, Andrew M Evens, Graham P Collins, Alexey V Danilov, Mark Bower, Deepa Jagadeesh, Catherine Zhu, Amy Sperling, Seo-Hyun Kim, Ryan Vaca, Catherine Wei, Suchitra Sundaram, Nishitha Reddy, Alessia Dalla Pria, Christopher R D'Angelo, Umar Farooq, David A Bond, Stephanie Berg, Michael C Churnetski, Amandeep Godara, Nadia Khan, Yun Kyong Choi, Shireen Kassam, Maryam Sarraf Yazdy, Emma Rabinovich, Frank A Post, Gaurav Varma, Reem Karmali, Madelyn Burkart, Peter Martin, Albert Ren, Ayushi Chauhan, Catherine S Diefenbach, Allandria Straker-Edwards, Andreas Klein, Kristie A Blum, Kirsten Marie Boughan, Agrima Mian, Bradley M Haverkos, Victor M Orellana-Noia, Vaishalee P Kenkre, Adam Stephen Zayac, Seth M Maliske, Narendranath Epperla, Paolo Caimi, Scott E Smith, Manali Kamdar, Parameswaran Venugopal, Tatyana A Feldman, Daniel Rector, Stephen Douglas Smith, Andrzej Stadnik, Craig A Portell, Yong Lin, Seema G Naik, Silvia Montoto, Izidore S Lossos, Kate Cwynarski
HIV-associated Burkitt lymphoma: outcomes from a US-UK collaborative analysis. Blood advances 5 (14) (2021)